Evaluated articles

Higher COVID-19 Vaccination Rates among Unemployed in the United States: State Level Study in the First 100 days of Vaccine Initiation

1. Ali Roghani
2. Samin Panahi

Reviewed by ScreenIT

Incidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms: A systematic review and meta-analysis

1. Hiroshi Hoshijima
2. Takahiro Mihara
3. Hiroyuki Seki
4. Shunsuke Hyuga
5. Norifumi Kuratani
6. Toshiya Shiga

Reviewed by ScreenIT

Development and Validation of the Long Coronavirus Disease (COVID) Symptom and Impact Tools: A Set of Patient-Reported Instruments Constructed From Patients’ Lived Experience

1. Viet-Thi Tran
2. Carolina Riveros
3. Bérangère Clepier
4. Moïse Desvarieux
5. Camille Collet
6. Youri Yordanov
7. Philippe Ravaud

Reviewed by ScreenIT

Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients

1. Ilies Benotmane
2. Gabriela Gautier-Vargas
3. Noëlle Cognard
4. Jérôme Olagne
5. Françoise Heibel
6. Laura Braun-Parvez
7. Jonas Martzloff
8. Peggy Perrin
9. Bruno Moulin
10. Samira Fafi-Kremer
11. Sophie Caillard

Reviewed by ScreenIT

A Novel Diagnostic Test to Screen SARS-CoV-2 Variants Containing E484K and N501Y Mutations

1. Yanan Zhao
2. Annie Lee
3. Kaelea Composto
4. Marcus H. Cunningham
5. Jose R. Mediavilla
6. Samantha Fennessey
7. André Corvelo
8. Kar Fai Chow
9. Michael Zody
10. Liang Chen
11. Barry N. Kreiswirth
12. David S. Perlin

Reviewed by ScreenIT

Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains

1. Nikhil Faulkner
2. Kevin W Ng
3. Mary Y Wu
4. Ruth Harvey
5. Marios Margaritis
6. Stavroula Paraskevopoulou
7. Catherine Houlihan
8. Saira Hussain
9. Maria Greco
10. William Bolland
11. Scott Warchal
12. Judith Heaney
13. Hannah Rickman
14. Moria Spyer
15. Daniel Frampton
16. Matthew Byott
17. Tulio de Oliveira
18. Alex Sigal
19. Svend Kjaer
20. Charles Swanton
21. Sonia Gandhi
22. Rupert Beale
23. Steve J Gamblin
24. John W McCauley
25. Rodney Stuart Daniels
26. Michael Howell
27. David Bauer
28. Eleni Nastouli
29. George Kassiotis

• Curated by eLife

  Evaluation Summary:

  This study describes reduced antibody cross-reactivity between the SARS-CoV-2 B.1.1.7 variant and the parental strain or the B.1.351 variant. Asymmetric antibody responses and reduced neutralizing antibodies against heterogeneous variants have been demonstrated in multiple studies. The current study reports reduction of B.1.1.7 COVID-19 sera against the SARS-CoV-2 parental strain and B.1.351. This observation is interesting and could be useful for future vaccine development. The work is of interest to virologists and infectious disease specialists.

  (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. The reviewers remained anonymous to the authors.)

Reviewed by eLife, ScreenIT

A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern

1. Matheus Filgueira Bezerra
2. Lais Ceschini Machado
3. Viviane do Carmo Vasconcelos De Carvalho
4. Cássia Docena
5. Sinval Pinto Brandão-Filho
6. Constância Flávia Junqueira Ayres
7. Marcelo Henrique Santos Paiva
8. Gabriel Luz Wallau

Reviewed by ScreenIT

Assessing the Mortality Impact of the COVID-19 Pandemic in Florida State Prisons

1. Neal Marcos Marquez
2. Aaron Littman
3. Victoria Rossi
4. Michael Everett
5. Erika Tyagi
6. Hope Johnson
7. Sharon Dolovich

Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis

1. Chee Keng Mok
2. Yan Ling Ng
3. Bintou Ahmadou Ahidjo
4. Regina Ching Hua Lee
5. Marcus Wing Choy Loe
6. Jing Liu
7. Kai Sen Tan
8. Parveen Kaur
9. Wee Joo Chng
10. John Eu-Li Wong
11. De Yun Wang
12. Erwei Hao
13. Xiaotao Hou
14. Yong Wah Tan
15. Tze Minn Mak
16. Cui Lin
17. Raymond Lin
18. Paul Tambyah
19. JiaGang Deng
20. Justin Jang Hann Chu

Reviewed by ScreenIT

The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA

1. Jasmine Cubuk
2. Jhullian J. Alston
3. J. Jeremías Incicco
4. Sukrit Singh
5. Melissa D. Stuchell-Brereton
6. Michael D. Ward
7. Maxwell I. Zimmerman
8. Neha Vithani
9. Daniel Griffith
10. Jason A. Wagoner
11. Gregory R. Bowman
12. Kathleen B. Hall
13. Andrea Soranno
14. Alex S. Holehouse

Reviewed by ScreenIT

Improving COVID-19 Testing Efficiency using Guided Agglomerative Sampling

1. Fayyaz Minhas
2. Dimitris Grammatopoulos
3. Lawrence Young
4. Imran Amin
5. David Snead
6. Neil Anderson
7. Asa Ben-Hur
8. Nasir Rajpoot

Reviewed by ScreenIT

Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses

1. Cedric C.S. Tan
2. Christopher J. Owen
3. Christine Y.L. Tham
4. Antonio Bertoletti
5. Lucy van Dorp
6. Francois Balloux

Reviewed by ScreenIT

A non-coding A-to-T Kozak site change related to the transmissibility of Alpha, Delta and Omicron VOCs

1. Jianing Yang
2. Guoqing Zhang
3. Dalang Yu
4. Ruifang Cao
5. Xiaoxian Wu
6. Yunchao Ling
7. Yi-Hsuan Pan
8. Chunyan Yi
9. Xiaoyu Sun
10. Bing Sun
11. Yu Zhang
12. Guo-Ping Zhao
13. Yixue Li
14. Haipeng Li

Reviewed by ScreenIT

Induction of SARS-CoV-2 protein S-specific CD8+ T cells in the lungs of gp96-Ig-S vaccinated mice

1. Eva Fisher
2. Laura Padula
3. Kristin Podack
4. Katelyn O’Neill
5. Matthew M Seavey
6. Padmini Jayaraman
7. Rahul Jasuja
8. Natasa Strbo

Reviewed by ScreenIT

Pre-treatment of the clinical sample with Proteinase K allows detection of SARS-CoV-2 in the absence of RNA extraction

1. Larissa Mallmann
2. Karoline Schallenberger
3. Meriane Demolliner
4. Ana Karolina Antunes Eisen
5. Bruna Saraiva Hermann
6. Fágner Henrique Heldt
7. Alana Witt Hansen
8. Fernando Rosado Spilki
9. Juliane Deise Fleck

Reviewed by ScreenIT

Coincident rapid expansion of two SARS-CoV-2 lineages with enhanced infectivity in Nigeria

1. Egon A. Ozer
2. Lacy M. Simons
3. Olubusuyi M. Adewumi
4. Adeola A. Fowotade
5. Ewean C. Omoruyi
6. Johnson A. Adeniji
7. Taylor J. Dean
8. Janet Zayas
9. Pavan P. Bhimalli
10. Michelle K. Ash
11. Adam Godzik
12. Jeffrey R. Schneider
13. João I. Mamede
14. Babafemi O. Taiwo
15. Judd F. Hultquist
16. Ramon Lorenzo-Redondo

Reviewed by ScreenIT

Structure-Based Design of a Cyclic Peptide Inhibitor of the SARS-CoV-2 Main Protease

1. Adam G. Kreutzer
2. Maj Krumberger
3. Chelsea Marie T. Parrocha
4. Michael A. Morris
5. Gretchen Guaglianone
6. James S. Nowick

Reviewed by ScreenIT

State minimum wage, paid sick leave, and food insufficiency during the COVID-19 pandemic

1. Julia Raifman
2. Elaine Nsoesie
3. Lorraine T. Dean
4. Katherine Gutierrez
5. Will Raderman
6. Alexandra Skinner
7. Paul Shafer

Reviewed by ScreenIT

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

1. Carlo Cervia
2. Jakob Nilsson
3. Yves Zurbuchen
4. Alan Valaperti
5. Jens Schreiner
6. Aline Wolfensberger
7. Miro E. Raeber
8. Sarah Adamo
9. Sebastian Weigang
10. Marc Emmenegger
11. Sara Hasler
12. Philipp P. Bosshard
13. Elena De Cecco
14. Esther Bächli
15. Alain Rudiger
16. Melina Stüssi-Helbling
17. Lars C. Huber
18. Annelies S. Zinkernagel
19. Dominik J. Schaer
20. Adriano Aguzzi
21. Georg Kochs
22. Ulrike Held
23. Elsbeth Probst-Müller
24. Silvana K. Rampini
25. Onur Boyman

Reviewed by ScreenIT

Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning

1. Shira Doron
2. Robin R. Ingalls
3. Anne Beauchamp
4. Jesse S. Boehm
5. Helen W. Boucher
6. Linda H. Chow
7. Linda Corridan
8. Katey Goehringer
9. Doug Golenbock
10. Liz Larsen
11. David Lussier
12. Marcia Testa
13. Andrea Ciaranello

Reviewed by ScreenIT